SCM
CASI

Sterneck Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Sterneck Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,000
Closed -$32K – 94
2022
Q1 		$32K Hold
4,000
– – 0.02% 100
2021
Q4 		$32K Hold
4,000
– – 0.02% 102
2021
Q3 		$48K Hold
4,000
– – 0.03% 97
2021
Q2 		$47K Buy
+4,000
New +$67.3K 0.03% 97

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sterneck Capital Management's CASI Position: Q2 2022 in Review

Sterneck Capital Management sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 4,000 shares — an estimated $32K sold.

Sterneck Capital Management first reported a position in CASI in Q2 2021 and held it in 4 quarters. The position peaked at $48K in Q3 2021. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

  • Sterneck Capital Management reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Sterneck Capital Management sold 4,000 CASI Pharmaceuticals shares in Q2 2022, an estimated $32K.
  • Sterneck Capital Management first reported a position in CASI Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Sterneck Capital Management's CASI Pharmaceuticals position peaked at $48K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Sterneck Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.